Loomis, Sayles & Company’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-16
Closed -$3K 1039
2023
Q2
$3K Buy
+16
New +$3.18K ﹤0.01% 936
2022
Q1
Sell
-725
Closed -$112K 1058
2021
Q4
$112K Buy
725
+93
+15% +$15.6K ﹤0.01% 600
2021
Q3
$107K Hold
632
﹤0.01% 576
2021
Q2
$100K Sell
632
-217
-26% -$32.2K ﹤0.01% 573
2021
Q1
$118K Sell
849
-64
-7% -$10.3K ﹤0.01% 547
2020
Q4
$160K Buy
913
+64
+8% +$11.9K ﹤0.01% 505
2020
Q3
$166K Hold
849
﹤0.01% 514
2020
Q2
$144K Sell
849
-130
-13% -$19.4K ﹤0.01% 510
2020
Q1
$113K Buy
979
+90
+10% +$9.97K ﹤0.01% 530
2019
Q4
$102K Buy
+889
New +$94.3K ﹤0.01% 579

Other funds holding SGEN

Loomis, Sayles & Company's SGEN Position: Q3 2023 in Review

Loomis, Sayles & Company sold out of Seagen Inc. Common Stock (SGEN) in Q3 2023, closing a stake of 16 shares — an estimated $3K sold.

Loomis, Sayles & Company first reported a position in SGEN in Q4 2019 and held it in 10 quarters. The position peaked at $166K in Q3 2020. 616 funds tracked by Wall St. Rank hold SGEN as of Q3 2023.

  • Loomis, Sayles & Company reported no remaining Seagen Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Loomis, Sayles & Company sold 16 Seagen Inc. Common Stock shares in Q3 2023, an estimated $3K.
  • Loomis, Sayles & Company first reported a position in Seagen Inc. Common Stock in Q4 2019 and held it in 10 quarters.
  • Loomis, Sayles & Company's Seagen Inc. Common Stock position peaked at $166K in Q3 2020.
  • 616 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2023.

Based on Loomis, Sayles & Company's 13F filing for Q3 2023, filed 9 Nov 2023.